EPO also decreased activated microglia expression in autoimmune encephalomyelitis, Alzheimer disease, and ischemic brain injury (Assaraf et al., 2007; Villa et al., 2003; Yuan et al., 2008). The gene discussed is EPO; the disease is early-onset autosomal dominant Alzheimer disease.